Related Experiment Videos
Two-step mechanism of macrophage-mediated tumor lysis in vitro
Abstract:
Normal peritoneal macrophages from C3H/He mice could not lyse syngeneic MM46 tumor cells in co-operation with syngeneic antitumor antibody. Thus, normal macrophages could not effectively participate in the antibody-dependent macrophage-mediated tumor lysis in vitro. However, after activation in vivo by stimuli, such as lipopolysaccharide, BCG, or glycogen, macrophages could co-operate with antitumor antibody in cytolysis of target cells. In the cytolysis nonspecific activation of normal macrophages was an essential first step, followed by specific tumor lysis in the presence of an antitumor antibody (second step). Immune macrophages from resistant mice were apparently equal in functional state to activated macrophages. A two-step mechanism of tumor lysis in vitro in a syngeneic mammary tumor system is proposed.
Insights
Normal macrophages cannot kill tumor cells with antibodies alone. Activation is required for macrophages to effectively mediate antibody-dependent tumor cell lysis, suggesting a two-step mechanism for effective cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Cytotoxicity
Background:
- Antibody-dependent cellular cytotoxicity (ADCC) is crucial for immune surveillance.
- Macrophages are key effector cells in ADCC, but their activation state influences efficacy.
- The role of macrophage activation in antibody-mediated tumor cell lysis requires further elucidation.
Purpose of the Study:
- To investigate the ability of normal and activated macrophages to mediate tumor cell lysis in the presence of antitumor antibodies.
- To determine the mechanism underlying antibody-dependent macrophage-mediated tumor lysis in a syngeneic model.
- To compare the functional capacity of in vivo-activated macrophages with immune macrophages.
Main Methods:
- Co-culture of C3H/He mice peritoneal macrophages (normal, activated, or immune) with syngeneic MM46 tumor cells.
- Addition of syngeneic antitumor antibody to assess antibody-dependent cell-mediated cytotoxicity (ADCC).
- Evaluation of tumor cell lysis using standard cytotoxicity assays.
Main Results:
- Normal macrophages did not lyse MM46 tumor cells, even with antitumor antibody.
- In vivo activation of macrophages (e.g., with LPS, BCG, glycogen) enabled antibody-dependent tumor cell lysis.
- A two-step mechanism was proposed: non-specific activation followed by specific antibody-mediated tumor cell killing.
- Immune macrophages from resistant mice exhibited functional capabilities similar to activated macrophages.
Conclusions:
- Macrophage activation is essential for effective antibody-dependent tumor cell lysis.
- A two-step process involving non-specific activation and specific antibody engagement underlies this cytotoxic mechanism.
- Activated or immune macrophages are superior to normal macrophages in antibody-dependent tumor cell killing, highlighting their potential in cancer immunotherapy.